Manoj et al. recently proposed that in the inflammatory response, chondrocytes undergo a metabolic shift regulated by NF-κB activation, which may lead to a shift in cellular metabolism toward glycolysis and lactate dehydrogenase A (LDHA) reprogramming, LDHA could be a new therapeutic target for osteoarthritis [50]. This evidence concerns the gene NFKB1 and osteoarthritis.